Hydrogen Peroxide

Hydrogen Peroxide

SCHEMBL6662236

CCn1c2ccccc2c2cc(N)ccc21.OO

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.93
MAPT P10636 7/20 0.93
KMT2A Q03164 4/20 0.93
ALDH1A1 P00352 4/20 0.93
MEN1 O00255 3/20 0.93
MAPK1 P28482 2/20 0.93
HTT P42858 2/20 0.93
HPGD P15428 1/20 0.93
HBB P68871 1/20 0.93
HSD17B10 Q99714 1/20 0.93
TDP1 Q9NUW8 1/20 0.93
LMNA P02545 5/20 0.58
POLB P06746 2/20 0.58
PKM P14618 1/20 0.56
NPSR1 Q6W5P4 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.52
SRC P12931 2/20 0.50
NPY5R Q15761 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SIGMAR1 Q99720 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357684 0.97 MAPT (1.00) KDM4EMAPTKMT2AALDH1A1MEN1
SCHEMBL37700 0.97 MAPT (1.00) KDM4EMAPTKMT2AALDH1A1MEN1
Water SCHEMBL28844053 0.95 MAPT (0.97) KDM4EMAPTKMT2AALDH1A1MEN1
Iodide SCHEMBL33722025 0.95 MAPT (0.97) KDM4EMAPTKMT2AALDH1A1MEN1
Acetic Acid SCHEMBL3457064 0.94 KDM4E (0.82) KDM4EMAPTKMT2AALDH1A1MEN1
1,2-Dichlorobenzene SCHEMBL28513476 0.89 MAPT (0.85) KDM4EMAPTKMT2AALDH1A1MEN1
Succinamide SCHEMBL9208547 0.88 KDM4E (0.78) KDM4EMAPTKMT2AALDH1A1MEN1
SCHEMBL350783 0.88 KDM4E (0.82) KDM4EMAPTKMT2AALDH1A1MEN1
SCHEMBL29411076 0.88 KDM4E (0.82) KDM4EMAPTKMT2AALDH1A1MEN1
SCHEMBL1683342 0.86 KDM4E (0.81) KDM4EMAPTKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9326993-B2 Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors ONCOGENEX TECHNOLOGIES INC. (CA) 2016-05-03 US disclosed
US-20150126584-A1 Treatment of Pulmonary and Pleural Fibrosis Using HSP27 Inhibitors ONCOGENEX TECHNOLOGIES INC. (CA) 2015-05-07 US disclosed
US-8987223-B2 Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors ONCOGENEX TECHNOLOGIES INC. (CA) 2015-03-24 US disclosed
US-20120294846-A1 Treatment of Pulmonary and Pleural Fibrosis Using HSP27 Inhibitors ONCOGENEX TECHNOLOGIES INC. (CA) 2012-11-22 US disclosed
EP-0912741-B1 T-CELL SELECTIVE INTERLEUKIN-4 AGONISTS BAYER AG (US) 2004-07-28 EP disclosed
US-6433157-B1 POLYNUCLEOTIDE MOLECULE ENCODING HUMAN INTERLEUKIN-4 MUTEIN HAVING MUTATED SURFACE EXPOSED RESIDUES OF D HELIX, WHICH CAUSES T-CELL PROLIFERATION AND REDUCED INTERLEUKIN-6 SECRETION FROM HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS BAYER CORPORATION 2002-08-13 US disclosed
US-5986059-A POLYPEPTIDES AND INTERLEUKINS BAYER CORPORATION (US) 1999-11-16 US disclosed
EP-0912741-A2 T-CELL SELECTIVE INTERLEUKIN-4 AGONISTS Bayer Corporation (US) 1999-05-06 EP disclosed
WO-1997047744-A2 T-CELL SELECTIVE INTERLEUKIN-4 AGONISTS BAYER CORPORATION (US) 1997-12-18 WO disclosed